# Arbutus Biopharma Corp: Form 8-K, filed Aug 10, 2016

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2016-08-10
- Accepted by EDGAR: Aug 10, 2016, 08:00 ET
- Period: 2016-08-10
- Accession: 0001171843-16-011661
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184316011661/f8k_080916.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184316011661/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184316011661/f8k_080916.htm

Filed Aug 10, 2016.
Source: SEC EDGAR, the filing index for accession 0001171843-16-011661. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
